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Five years of cardio-ankle vascular index (CAVI) and
CAVI0: how close are we to a pressure-independent
index of arterial stiffness?
Alessandro Giudicia,b, Ashraf W. Khira, Koen D. Reesinkb, Tammo Delhaasb, and Bart Spronckb,c
Pulse wave velocity, a common metric of arterial stiffness,
is an established predictor for cardiovascular events and
mortality. However, its intrinsic pressure-dependency
complicates the discrimination of acute and chronic
impacts of increased blood pressure on arterial stiffness.
Cardio-ankle vascular index (CAVI) represented a
significant step towards the development of a pressure-
independent arterial stiffness metric. However, some
potential limitations of CAVI might render this arterial
stiffness metric less pressure-independent than originally
thought. For this reason, we later introduced CAVI0.
Nevertheless, advantages of one approach over the other
are left debated. This review aims to shed light on the
pressure (in)dependency of both CAVI and CAVI0. By
critically reviewing results from studies reporting both CAVI
and CAVI0 and using simple analytical methods, we show
that CAVI0 may enhance the pressure-independent
assessment of arterial stiffness, especially in the
presence of large inter-individual differences in blood
pressure.
Keywords: arterial stiffness, cardio-ankle vascular index,
CAVI0, pressure-dependency, pulse wave velocity
Abbreviations: r, blood density; b, Kawasaki’s stiffness
index beta; b0, Hayashi’s normalized stiffness index beta; a
and b, scaling coefficients to transform CAVIuns into CAVI;
A, lumen cross-sectional area; BP, blood pressure; CAVI,
cardio-ankle vascular index; CAVI0, modified CAVI;
CAVIuns, unscaled CAVI; D, diameter; Dd, diastolic
diameter; Dref, reference diameter; Ds, systolic diameter;
haPWV, heart-to-ankle PWV; L, heart-to-ankle arterial
pathway length; L-CAVI, left CAVI; L-haPWV, left haPWV;
MBP, mean blood pressure; P, pressure; PhaPWV, haPWV-
relevant pressure; Pm, mid pressure calculated as arithmetic
mean of SBP and DBP; Pref, reference pressure; PWV, pulse
wave velocity; R-CAVI, right CAVI; R-haPWV, right haPWV;
tb, time difference between the second heart sound and
the dicrotic notch of the brachial pressure waveform; tba,




rterial stiffness measures based on pulse wave
velocity (PWV) have become established predictors
for cardiovascular disease and mortality [1,2]. How-
ever, the highly nonlinear mechanical behaviour of the
arterial wall makes arterial stiffness and related metrics
intrinsically dependent on blood pressure (BP) [3–8]. This
aspect of arterial wall mechanics complicates the use of
PWV in clinical practice, as inter-individual or inter-clinical-
group arterial stiffness differences may be caused by either
actual differences in arterial structure and mechanics, differ-
ences in BP level at the time of measurement, or, most
likely, a combination of the two. Most clinical studies
address this issue by using statistical methods and including
BP as confounding factor [9–11]. Although this approach
has proven effective in population studies, it is not patient-
specific and, therefore, is not applicable in daily clinical
practice. Furthermore and more fundamentally, statistical
blood pressure correction of PWV may lead to overcorrec-
tion and may, for example, conceal intrinsic hypertensive
remodeling [12].
Researchers have devised different methods for person-
specific pressure-normalization of PWV [4,13,14] that would
allow converting the measured PWV to that at a reference
pressure (Pref), thus discerning between actual stiffness
differences among people and those induced by pressure.
Hayashi et al. [5] introduced an approach based on the
observation that, in the physiological range of pressure, the
pressure—diameter (P–D) relationship of arteries strongly
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resembles an exponential function and proposed the fol-
lowing exponential tube law








where P is the arterial pressure, D is the luminal diameter,
Pref is a reference pressure, Dref is the corresponding
reference diameter (from Eq. 1, P(Dref) ¼ Pref), and b0 is
an exponential gain. An interesting feature of Eq. 1 is that
the same P-D relationship can be obtained by different
combinations of Pref (and consequently Dref) and b0 (Fig. 1),
so that b0 is intrinsically dependent on the choice of Pref.
However, when Pref is fixed to a constant value and Eq. 1 is
used to fit the P-D relationships of different individuals, b0
becomes a pressure-normalized index of arterial stiffness.
‘Pressure-normalized’ here means that, while b0 is still
pressure-dependent (i.e. dependent on the choice of Pref),
using a fixed Pref guarantees that inter-individual differ-
ences in b0 are unaffected by inter-individual differences in
BP at the time of measurement. Notably, b0 is not a PWV
measure – b0 defines arterial stiffening with increasing
pressure.
The exponential tube law introduced by Hayashi paved
the way for the development of methods allowing for the
patient-specific pressure-normalization of PWV. In 2006,
Shirai et al. [15] introduced cardio-ankle vascular index
(CAVI), followed in 2017 by the introduction of CAVI0
by our group [16]. Both CAVI and CAVI0 aim to provide
a pressure-independent arterial stiffness index, similar to
Hayashi’s b0; however, now representing the entire heart-
to-ankle arterial bed. Researchers have used both CAVI and
CAVI0 to investigate arterial stiffness independently of BP,
and the advantages of one technique over the other are still
subject of debate. This review aims to address this debate by
analysing the current scientific evidence in support of the
two metrics. It will first provide an overview of the theoret-
ical background, then summarize all the studies where both
CAVI and CAVI0 were used to normalize PWV, and finally
discuss their findings in light of the unresolved questions
concerning the two metrics.
Cardio-ankle vascular index
Following the work of Hayashi et al. [5] and with the intent
of establishing a pressure-independent PWV metric, in
2006, Shirai et al. [15] introduced CAVI. With reference
to Eq. 1, Shirai and colleagues set Pref to the individual-
specific DBP (Eq. 2), as previously proposed by Kawasaki
et al. [17]:








where Dd is the arterial diastolic diameter and b is the value
of b0 when Pref is set to the individual-specific DBP. The
Bramwell–Hill equation (Eq. 3) [18] is an established equa-












which is approximated as
PWV 
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
Ds SBP DBPð Þ
2r Ds  Ddð Þ
s
; (4)
where Ds is the arterial systolic diameter, and r is the blood
mass density. Combining Eqs. 2 and 4, leads to a quadratic
relationship between b and PWV:





SBP DBP ¼ CAVIuns ; (5)
where CAVIuns is the unscaled CAVI. Later, Shirai [19]






where Pm, the mid pressure, is the arithmetic mean of SBP
and DBP [Pm ¼ (SBP þ DBP)/2)]. Pm should not be
confused with the mean BP (MBP or MAP, mean arterial
pressure) which is the average pressure over a cardiac
cycle.
Shirai et al. replaced the local PWV in Eq. 5 with the
heart-to-ankle PWV (haPWV), that is, a regional PWV
calculated over the arterial pathway connecting the aortic
valve and the end of the anterior tibial artery (ankle), hence,
extending the application of the local exponential P-D
modelling approach to large regions of the arterial tree.
The methodology employed for the measurement of
haPWV by the commercial VaSera device (VS 1500, Fukuda
Denshi Co., Japan) is represented in Fig. 2. Briefly, haPWV
is calculated as L/(tbþ tba), where L is the heart-to-ankle
arterial pathway length and the sum of tb and tba con-
stitutes the heart-to-ankle transit time (Fig. 2). tb is the time
difference between the second heart sound (i.e. closure of
the aortic valve) and the dicrotic notch of the brachial
pressure waveform, and tba is the time between the feet
of the brachial and ankle pressure waveforms. It is worth
considering that tb and tba take as reference two different
FIGURE 1 Examples of identical exponential pressure–diameter relationships (Eq. 1)
calculated using different combinations of the reference pressure Pref (and corre-
sponding reference diameter Dref) and stiffness parameter b0.
Giudici et al.
2 www.jhypertension.com Volume 39  Number 1  Month 2021
CE: Tripti; JH-D-21-00511; Total nos of Pages: 11;
JH-D-21-00511
points within the cardiac cycle: the dicrotic notch and the
foot of the wave, respectively. The VaSera device allows for
the estimation of the right haPWV (R-haPWV) using the
pressure waveforms of the right arm and right ankle as well
as of the left haPWV (L-haPWV) where the right ankle is
substituted by the left one (i.e. still the right brachial
pressure is used) [20,21]. CAVI is finally calculated by
transforming CAVIuns using:
CAVI ¼ a  CAVIuns þ b : (7)
It is worth noting that a and b are not the same for all
values of CAVIuns. Eq. 7 is, in fact, a three-piecewise
linear function, where a and b are 0.85 and 0.695 when
FIGURE 2 Schematic representation of the algorithm used in the calculation of the heart-to-ankle pulse wave velocity, which is the basis of both cardio-ankle vascular
index and CAVI0. The heart-to-ankle transit time is determined as the sum of the transit time between the second heart sound, corresponding to the closure of the aortic
valve, and the dicrotic notch in the brachial artery pressure (P) waveform (tb), and the time difference between the feet of the brachial and ankle pressure waveforms
(tba). CAVI0, modified cardio-ankle vascular index. L denotes the length of the heart-to-ankle arterial trajectory.
CAVI and CAVI0: a review
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CAVIuns < 7.34875, 0.658 and 2.103 when 7.34875 
CAVIuns < 10.30372, and 0.432 and 4.441 when CAVIuns
 10.30372 [21,22]. This transformation is performed to
ensure that the age trend of CAVI quantitatively resembles
that of the Hasegawa PWV [23], a commonly used PWV
metric in Japan at the time of the development of CAVI [21].
Following the body side-specific haPWV, right (R-CAVI)
and left CAVI (L-CAVI) are obtained when R-haPWV and L-
haPWV, respectively, are substituted for PWV in Eq. 5.
Modified cardio-ankle vascular index
Although CAVI has been considered for more than 15 years
as a pressure-independent index of arterial stiffness, in
2017, we published a work [16] that analytically suggested
a residual pressure dependency of CAVI. Our demonstra-
tion is based on two observations.
First, as mentioned above, Shirai’s derivation of CAVI is
based on the simplified exponential function proposed by
Kawasaki (Eq. 2). Therefore, contrarily to b0 (Eq. 1), b is not
pressure-normalized and depends on the individual spe-
cific DBP [24]. It can be shown that b and b0 are linked by
the following relationship:





Figure 3 shows the magnitude of the difference between the
pressure-dependent b and the pressure-normalized b0 as a
function of the ratio DBP/Pref, providing an example of
how this difference can affect the inter-individual compari-
son between clinical groups with inherent differences
in DBP.
Second, the derivation of the CAVI formula uses a
simplified version of the Bramwell–Hill equation (Eq. 4)
where a linear approximation over the DBP-to-SBP range
(see Eqs. 3 and 4 and Appendix 1, http://links.lww.com/
HJH/B719) is used as an estimate of the infinitesimal dP/dD.
Similarly, the approximation introduced in Eq. 6 is accurate
only over infinitesimally small pressure intervals, hence
using Pm as the arithmetic mean of SBP and DBP will
inevitably introduce inaccuracies in the estimation of b.
To overcome the limitations and correct the residual
pressure dependency of CAVI, we proposed CAVI0 [16],
based on b0 and on the calculation of the exact derivative








Note that, if the chosen PWV is purely diastolic (e.g. foot-to-
foot PWVs), the first term in Eq. 9 equals b, so that
CAVI0¼b0 (Eq. 8). In our previous publications [16,20],
we proposed setting Pref to 100 mmHg. Although Pref does
not represent a physiological pressure, fixing Pref to a
pressure in the physiological range may be advantageous.
Choosing Pref within the physiological range ensures that,
on average, patient-specific corrections from b to b0 are
minimized. Furthermore, several studies reporting CAVI0
[25–29] adopted the same choice, thus ensuring direct
comparability of CAVI0 values between studies. As men-
tioned in the Background section, choosing a fixed Pref
makes b0 and, consequently, CAVI0 pressure-normalized
indices of arterial stiffness but these are still pressure (Pref)-
dependent. Therefore, results from studies using different
Pref should not be directly compared (i.e. a conversion
using Eq. 8 is needed). It can be shown that CAVI0 relates















We created a conversion tool/calculator to simplifiy this
conversion while taking into account the different values of





The only inclusion criterium of our literature review was
that the study had to report both CAVI and CAVI0 in either
the manuscript main text or the data supplement. Our
literature search proceeded in two steps: first, given the
relatively recent introduction of CAVI0, we reviewed all
studies citing the original CAVI0 publications [14,16,20].
This first search led to 14 papers (Table 1). Then, we
conducted a second literature search on PubMed, using
‘CAVI’ and ‘stiffness’ as search words and excluding all
studies published before 2017 – the year CAVI0 was intro-
duced. This second search produced 215 results, which,
after application of our inclusion criteria, reduced to the
same 14 studies achieved via the first search (Table 1).
The 14 included studies consisted of one computational
study, two longitudinal studies on the effect of acute
changes in blood pressure on CAVI and CAVI0, three
clinical longitudinal studies, and eight clinical cross-
FIGURE 3 Graphical representation of the magnitude of the logarithmic term that
differentiates between stiffness index b and b0 as a function of the ratio between
DBP and reference pressure (Pref). Note that this b0b difference represents one
of the two differences between cardio-ankle vascular index (CAVI) and modified
cardio-ankle vascular index (CAVI0) (the other difference being the use of an
approximated vs. infinitesimal derivative of the pressure–diameter relationship).
Arrows indicate examples, taken from data in [39], of how omitting the logarith-
mic term can affect the comparison between clinical groups.
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sectional studies. The evidence found in these manuscripts
will be reported following a study-type rationale rather than
a strictly chronological order.
Computational study
In 2017, alongside the analytical proof of the residual
pressure dependency of CAVI and introduction of the
adjusted CAVI0 metric, we provided a computational com-
parison of the two metrics [16]. The computational model
chosen assumed, in agreement with Hayashi’s findings, an
exponential P–D relationship (Eq. 1). Simulations showed
that b showed residual pressure dependency on DBP, CAVI
showed dependency on both DBP and SBP and CAVI0 did
not show such dependencies. More importantly, the mag-
nitude of the residual pressure-dependency of CAVI was
comparable with the intra-individual variability. It is worth
noting, however, that in these simulations, PWV was
assumed to arise purely from a foot-to-foot estimation,
whereas in the VaSera device, part of the estimation is
TABLE 1. Summary of all the studies that reported both cardio-ankle vascular index and modified cardio-ankle vascular index
Literature on the comparison between CAVI and CAVI0
First author
[reference] Type of study Sample size
Spronck [16] Computational N/A (161 in silico) Provided the analytical basis behind the pressure-dependency of CAVI.
Demonstrated computationally the residual pressure-dependency of both b (from DBP alone)
and CAVI (from both SBP and DBP).
Showed computationally that the size of the error produced in CAVI by its pressure
dependency is comparable to its intra-individual variability.
Showed computationally that CAVI0 is pressure-independent (also see Spronck 2018) [51].
Shirai [30] Clinical longitudinal 9 Both CAVI and CAVI0 did not change significantly after administration of BP lowering
metoprolol.
Mestanik [25] Clinical cross-sectional 140 Studied differences in CAVI and CAVI0 between normal-weight normotensive (n¼40),
overweight normotensive (n¼30), overweight white-coat hypertensive (n¼30), and
overweight essential hypertensive (n¼40) boys.
CAVI, but not CAVI0, was significantly higher in overweight white-coat hypertensive than in
overweight normotensives.
CAVI, but not CAVI0, showed significant correlation with DBP and PP.
Mills [42,43] Clinical longitudinal 126 Spironolactone and doxazosin reduced SBP similarly. Changes in CAVI and CAVI0 did not
differ between spironolactone and doxazosin treatment groups.
Beetroot juice containing nitrate reduced SBP similar to beetroot juice without nitrate.
Changes in CAVI and CAVI0 did not differ between groups.
Wohlfahrt [26] Clinical cross-sectional 2084 Provided reference values of CAVI and CAVI0 in a white population with no cardiovascular
disease.
CAVI and CAVI0 showed similar levels of correlation with BP that were much weaker than
those of haPWV.
Shirai [19] Clinical cross-sectional 3591 Pm showed a higher correlation with haPWV than both DBP and SBP.
Tabara [28] Clinical cross-sectional 9501 Close correlation between CAVI and CAVI0.
The residual of the regression between CAVI and CAVI0 presented a weak but significant
association with SBP.
Shirai [39] Clinical cross-sectional 8631 Compared CAVI and CAVI0 in population of 5293 healthy and 3338 hypertensive people.
Showed that CAVI shows a positive correlation with DBP, while such correlation is negative
for CAVI0.
Compared decade-specific differences in CAVI and CAVI0 between controls and hypertensive
patients. CAVI was always significantly higher in hypertensive men and women than age-
matched controls (except women in their 30s). This was also the case for CAVI0 in people
above 50 years, while younger hypertensive people showed comparable, if not lower
(women aged 30–39), CAVI0 than age-matched controls.
Among SBP, DBP and Pm, Pm showed the highest correlation with haPWV in all decade-
groups of control people.
Adding the reference pressure term ln(Pm/Pref) had negligible, nonsignificant effect on CAVI.
Mestanik [28] Clinical longitudinal 60 Studied changes in CAVI and CAVI0 in response to acute blood pressure (BP) changes during
cold pressor test.
CAVI significantly increased in response to and positively correlated with changes in BP.
CAVI0 did not change throughout the test and did not correlate with BP.
Czippelova [29] Clinical cross-sectional 58 Both CAVI and CAVI0 were significantly lower in young obese adolescents than age-matched
controls.
Strong correlation between CAVI and CAVI0 in both obese and normal-weight adolescents.
Tonhajzerova [33] Clinical cross-sectional 60 Studied differences in CAVI and CAVI0 between healthy, anorexic, and obese adolescent girls.
Similar statistical differences between groups when using CAVI and CAVI0.
Kim [32] Clinical cross-sectional 85 Studied differences in CAVI and CAVI0 between women with polycystic ovary syndrome
(PCOS) and controls.
Results obtained with CAVI and CAVI0 were statistically similar, except for the correlation
with age in women with PCOS that was significant in CAVI but not in CAVI0.
Itano [40] Clinical longitudinal 25 653 Studied association of CAVI with kidney function in adults without chronic kidney disease.
Close correlation between CAVI and CAVI0.
Similar results obtained using the two metrics.
Spronck [41] Clinical longitudinal 156 Showed that both right CAVI and right CAVI0 but not left CAVI and left CAVI0, predicted
heart-failure related end points in a population of 156 individuals.
Possible body-side difference in the prediction power of CAVI and CAVI0.
b, stiffness indiex b’, (Eq. 2); b0, pressure-normalized index of arterial stiffness (Eq. 1); BP, blood pressure; CAVI, cardio–ankle vascular index; CAVI0, modified cardio–ankle vascular
index; haPWV, heart-to-ankle pulse wave velocity; Pm, mid pressure; PP, pulse pressure; Pref, reference pressure.
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based on the dicrotic notch, where pressure is higher than
DBP (see Fig. 2 and Discussion).
Longitudinal studies on treatment-induced
acute changes in blood pressure
Longitudinal studies on the effect of treatment-induced
acute changes in BP represent, in our opinion, the ideal
setting to study the pressure-(in)dependency of a proposed
arterial stiffness metric, as acute changes in BP and stiffness
can be monitored simultaneously on a defined group of
individuals. However, administration of drugs or manoeu-
vres to produce acute changes in BP level can potentially
affect the vascular tone, thus altering the intrinsic and
pressure-independent stiffness of the arterial wall and
complicating the evaluation of the pressure dependence
of the proposed stiffness metrics.
Shirai et al. [30] published a partial reanalysis of previ-
ously published data (9 out of 12 individuals from [31]) on
the pressure-dependence of CAVI and brachial–ankle PWV
(baPWV), extending it to CAVI0. This study uses adminis-
tration of Metoprolol to decrease BP through decreasing
heart rate and ventricular contractility, and Doxazosin to
decrease BP by reducing smooth muscle tone. Both drugs
produced a significant drop in both SBP and DBP, with
consequent decreases in baPWV. On the contrary, both
CAVI and CAVI0 remained unchanged after the administra-
tion of Metoprolol but significantly decreased with Dox-
azosin. The authors concluded that both CAVI and CAVI0
proved to be pressure-independent as they were not
affected by the BP changes after the administration of
Metoprolol. In contrast, Doxazosin likely affected also
the vascular tone, thus affecting the intrinsic arterial stiff-
ness. Note, however that the existing methodological differ-
ences between CAVI and CAVI0 imply that the two metrics
cannot be both pressure-independent. Therefore, this find-
ing suggests that the sample size of this study might have
been too small to statistically detect the difference in
pressure dependency between the proposed arterial stiff-
ness metrics. Indeed, more recently, Mestanik et al. [28]
presented preliminary results on changes in CAVI and
CAVI0 in response to the cold pressor test and isometric
handgrip exercise in 60 healthy adults. Their results showed
that CAVI was significantly affected by and showed corre-
lation with changes in BP. Conversely, CAVI0 did not
change throughout the test and did not correlate with BP.
Clinical cross-sectional studies
Most of the articles reporting both CAVI and CAVI0 are
clinical, mostly cross-sectional, studies where the two met-
rics were used to compare arterial stiffness of different
clinical groups. Hence, demonstrating the advantages of
one method over the other was, in most cases, not the main
aim of these works. Furthermore, studying the pressure-
(in)dependency of CAVI and CAVI0 using cross-sectional
data is problematic. It is known, for example, that people
who are exposed to increased levels of arterial pressure
tend to have stiffer arteries than healthy normotensive
people. Therefore, even pressure-independent arterial stiff-
ness metrics will likely show correlation with BP over the
entire population. Most clinical cross-sectional studies
reported that results obtained with CAVI and CAVI0 are
similar from a statistical standpoint (i.e. statistical differ-
ences between the groups included in the studies were
comparable when using the two metrics). Wohlfahrt et al.
[26] reported reference values of CAVI and CAVI0 in a
population with no cardiovascular disease and found simi-
lar correlations with BP for the two metrics. Kim et al. [32]
studied differences in CAVI and CAVI0 in Korean women
with and without polycystic ovary syndrome and stated that
the two methods provided similar statistical results.
Three studies investigated the effect of weight on arterial
stiffness in adolescents. Overall, CAVI and CAVI0 agreed in
identifying lower values of arterial stiffness in obese and
overweight adolescents than age-matched normal-weight
healthy people [25,29,33], while increased CAVI and CAVI0
were found in anorexic girls [33], consistent with previous
literature on the (inverse) relationship between CAVI and
BMI [27,34,35]. Further, Mestanik et al. [25] found that
differences in both CAVI and CAVI0 between overweight
and normal-weight adolescents were no more significant
when overweight young people were also hypertensive.
Interestingly, however, when using CAVI, also overweight
white-coat hypertensive patients appeared to have higher
levels of arterial stiffness than overweight normotensive
individuals. Such difference was not found when using
CAVI0. The authors suggested that the residual pressure-
dependency of CAVI could possibly explain this discordant
result; as the effects of white-coat hypertension on actual
(pressure-independent) arterial stiffness seem marginal
[36–38], increased CAVI in this group might reflect their
high BP at the time of examination.
Shirai and colleagues [39] compared the pressure adjust-
ment provided by CAVI and CAVI0 in a large cohort of
normotensive and hypertensive Japanese people. Both
metrics showed a significant cross-sectional correlation
with SBP in both the hypertensive and normotensive
groups, while disagreement between the two techniques
was found in terms of relationship with DBP: CAVI showed
a significant positive correlation with DBP in the normo-
tensive group only. On the other hand, CAVI0 presented a
significant negative correlation with DBP in both groups.
Further, while dividing participants in decade age-groups
and stratifying by sex, they evaluated differences in CAVI
and CAVI0 between hypertensive patients and normoten-
sive individuals. In both men and women, the two metrics
indicated higher level of arterial stiffness in hypertensive
people aged at least 50 years than in age-matched normo-
tensives. On the contrary, in younger individuals, the results
provided by CAVI and CAVI0 did not agree; in men aged
30–39 years and in people of both sexes aged 40–49 years,
CAVI was significantly lower in normotensive individuals
than in hypertensive patients, while differences in CAVI0
were not significant. Further, in women in their 30 s, CAVI0
was significantly lower in hypertensive patients than nor-
motensive individuals, whereas CAVI did not differ in the
two groups. Finally, Shirai and colleagues reported that
including the –ln(DBP/Pref) term produced a 1.09 1.39
and 3.68 1.66% increase in the CAVI value provided by
the VaSera device in normotensive individuals and hyper-
tensive patients, respectively. The authors suggested that
the high dependency of CAVI0 on DBP could explain two
Giudici et al.
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unexpected findings: the negative correlation between
CAVI0 and DBP and the lower values of CAVI0 found in
young hypertensive women compared with age-matched
and sex-matched normotensive individuals. Additionally, to
advocate for the use of Pm (Eq. 6) over that of DBP (Eq. 9),
they reported that the cross-sectional correlation of haPWV
with Pm was stronger than its correlation with either SBP or
DBP in the healthy normotensive population [19,39], and
this was the case also when people were stratified in decade
age-groups.
Clinical longitudinal studies
We found four clinical longitudinal studies where both
CAVI and CAVI0 were included in the analysis. Tabara
et al. [28] studied factors influencing changes in CAVI
and CAVI0 between baseline and 5 years, follow-up in
the Nagahama study. In agreement with other studies
[26,29], the authors found a strong correlation between
CAVI and CAVI0. Interestingly, but not unexpectedly, the
residuals of the linear regression between the two metrics
significantly correlated with SBP. Indeed, CAVI (Eq. 6)
estimates b from PWV and 	Pm (depending on both SBP
and DBP), whereas, in CAVI0, the Pm is substituted by DBP
(Eq. 9), thus explaining why residuals between the two
metrics are related to SBP.
Itano et al. [40] found that patients with a CAVI of at least
8.1 had an elevated risk of chronic kidney disease events
compared with those patients with lower CAVI. Performing
the analysis using CAVI0 yielded similar results. We investi-
gated the ability of R-CAVI, L-CAVI, R-CAVI0 and L-CAVI0 of
predicting heart failure-related endpoints and found that
only R-CAVI and R-CAVI0 had predictive power [41].
Finally, the VaSera trial [42,43] is a double-blinded, parallel,
randomized controlled intervention trial evaluating the
effect of four interventions (spironolactone, doxazosin,
dietary nitrate beetroot juice, and nitrate-free beetroot
juice) on arterial stiffness. The authors found that spirono-
lactone and doxazosin had similar effects on SBP, CAVI and
CAVI0, as did dietary nitrate beetroot juice and nitrate-free
beetroot juice. The interested reader is referred to the
original publications for more details.
DISCUSSION
The development of methods that allow the pressure-nor-
malization of PWV is of crucial clinical importance [12]. The
introduction of CAVI in 2006 represented a considerable,
though not complete step towards an effective and, possi-
bly more important, convenient way to account for the
contribution of pressure to regional (heart-to-ankle) PWV,
providing patient-specific corrections. In 2017, we pro-
posed a modified metric, CAVI0, that aimed to improve
pressure-independency by targeting two critical points: b is
based on the individual-specific DBP and is, therefore,
intrinsically pressure-dependent, and the use of a linearized
Bramwell–Hill equation over the noninfinitesimal DBP-to-
SBP pressure range introduces inaccuracies. As advantages
of one technique over the other are still subject of debate,
this discussion section will be focused on untangling these
two points in the light of the scientific evidence reported
in the previous paragraphs and with the objective of
understanding how close we are to defining a pressure-
independent index of arterial stiffness.
The introductory paragraphs explained in detail the
difference between Hayashi’s b0 and Kawasaki’s b.
Although both metrics intrinsically depend on the reference
pressure chosen to define the exponential P-D relationship,
b0 uses the same Pref for all individuals whereas b is based
on the individuals-specific DBP. Hence, while the first can
be considered a pressure-normalized index of arterial stiff-
ness, the second maintains a residual pressure dependency.
b and b0 are linked by a simple equation (Eq. 8), so that b0
can easily be calculated from b by subtracting ln(DBP/Pref).
Shirai and colleagues advocated that subtraction of this
term to the standard b induces a negligible effect [39,44].
However, a careful analysis indicates that this effect is not
negligible when comparing groups with large differences in
DBP. Figure 3 shows the magnitude of the logarithmic term
as a function of DBP. In the study of Shirai et al. [39], DBP
ranged from approximately 70–117 mmHg in hypertensive
people and from approximately 58–82 mmHg in normo-
tensive individuals. Differences were particularly high in
young people (30–39 years), when the average DBP was
100 mmHg in hypertensive individuals (men and women)
and approximately 70 and 65mmHg in normotensive men
and women, respectively. Assuming Pref¼ 100 mmHg, the
average contribution of the logarithmic term in hyperten-
sive patients aged 30–39 years is null. On the contrary, in
normotensive people of the same age-group the average
difference between b and b0 is approximately 0.36 and 0.43
in men and women (Fig. 3), respectively, that translate into
	0.30 and 0.35 in terms of CAVI. It is worth observing that
the reported differences in CAVI between groups in this age
range were comparable with, if not smaller than, these
values. This simple example illustrates how omitting the
logarithmic term can lead to potentially significant errors in
the evaluation of arterial stiffness and misinterpretation of
differences between clinical groups. Indeed, while Shirai
and colleagues questioned the validity of CAVI0 on the basis
of surprisingly lower average CAVI0 found in young hyper-
tensive women compared with age-matched normoten-
sives, subtracting ln(DBP/Pref) from the normal CAVI,
that is, normalizing the pressure-dependent b to a fixed
Pref, seems to provide the same outcome. Furthermore,
these errors are calculated using average DBP values;
patient-specific errors may be even higher. We do not deny
that the average contribution of the logarithmic term in the
overall population might be small, especially when inter-
individual differences in DBP are relatively small [26,32].
Conversely, this contribution might become nonnegligible
when clinical groups are characterized by significantly
different pressures [25]. Furthermore, providing a group-
based pressure-normalization of PWV is neither the goal of
CAVI or CAVI0 as similar corrections can be obtained with
established statistical methods. In light of the considerations
detailed above and the fact that b0 can be easily determined
from b without the necessity of further measurements, it
seems logical and useful to use the proposed methodologi-
cal adjustment factor.
The second difference between the CAVI and CAVI0
formulas consists in the calculation of the derivative term
in the Bramwell–Hill equation. In CAVI, such derivative is
CAVI and CAVI0: a review
Journal of Hypertension www.jhypertension.com 7
CE: Tripti; JH-D-21-00511; Total nos of Pages: 11;
JH-D-21-00511
approximated through a linearization of the exponential
P-D relationship over the DBP-to-SBP pressure range,
whereas in CAVI0, the exact derivative is calculated at
diastolic pressure (Fig. 4). As shown previously [19], the
linearization used in CAVI is close, although not mathemat-
ically equal, to calculating the derivative at the Pm. It is
worth noting that Eq. 6 can be obtained without approx-
imations if Eq. 2 is redefined with respect to Pm instead of
DBP (see Appendix 2, http://links.lww.com/HJH/B719).
This suggests that the approximation introduced by Eq. 6
alters the meaning of CAVIuns, which no longer approx-
imates Kawasaki’s b as it arises from a Pm-based rather than
DBP-based exponential P-D relationship (Eq. 2 vs. Eq. A6).
Nevertheless, the diatribe between the two methods
reduces to determining what is the pressure level at which
haPWV is calculated. Before proceeding, it is worth con-
sidering that both CAVI and CAVI0 apply a single-exponen-
tial P-D model to a large region of the arterial tree (heart-to-
ankle). Clearly, along this region, both diameter and stiff-
ness vary, and a single unique physical relationship
between pressure and diameter is a simplification of reality.
Therefore, this diatribe cannot be resolved by solving the
inverse problem of determining the pressure at which
haPWV is calculated knowing both b and haPWV. Hence,
the choice of the best method has to be made based on
methodological observations.
Shirai and colleagues adduced different justifications for
the choice of Pm over DBP [39,44]; the first is based on the
observation that, in cross-sectional studies, haPWV shows a
higher correlation with Pm than with both SBP and DBP.
However, as stated previously, cross-sectional studies can
lead to confusing results concerning the dependency of
PWV on BP as cross-sectional correlation arises from a
combination of acute and chronic effects of BP on PWV.
To understand this concept, it is useful to consider that the
current guidelines for the diagnosis of hypertension are
based on SBP and/or DBP overcoming a predefined thresh-
old (e.g. 140 and 90mmHg, respectively, in Europe). As
hypertension and elevated BP are associated with arterial
stiffening, it is likely that people with increased DBP, SBP,
or both will have increased PWV. As Pm summarizes both
DBP and SBP, it is not surprising that Pm, and not DBP or
SBP individually, shows the highest correlation with
haPWV. In a hypothetical population where some individ-
uals present an elevated SBP but none has elevated DBP,
haPWV would likely show higher correlation with SBP than
with both Pm and DBP. Therefore, the high cross-sectional
correlation of haPWV with Pm is hardly an incontrovertible
proof of the fact that haPWV is determined at mid pressure.
Methodological observation can guide towards educated
guesses when the solution to a problem cannot be achieved
with strict scientific proof. For instance, as the CAVI and
CAVI0 equations to estimate b and b0 can, in principle, be
applied to PWV estimated using any method, the assump-
tion that the DBP is the PWV-relevant pressure level seems
reasonable for all the foot-to-foot PWV metrics (e.g.
carotid–femoral PWV, brachial–ankle PWV) [44]. Indeed,
the reference points used for the calculation of the transit
FIGURE 4 Summary of the methodological differences between cardio-ankle vascular index and modified cardio-ankle vascular index. Cardio-ankle vascular index (CAVI)
approximates the derivative term in the Bramwell–Hill equation with differences over the SBP to DBP blood pressure range. Conversely, modified cardio-ankle vascular
index (CAVI0) uses the exact derivative at DBP. haPWV, heart to ankle pulse wave velocity.
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time correspond to the foot of the systolic upstroke when
pressure equals DBP. However, as illustrated in Fig. 2, the
algorithm used for the determination of haPWV, and thus
CAVI/CAVI0 is more complex and entails two time differ-
ences calculated at different pressure levels: dicrotic notch
for tb and foot for tba. On one side, this algorithm has the
advantage of including the ascending aorta in the haPWV
arterial pathway, whereas this proximal segment is
excluded in the more widely used carotid–femoral PWV.
On the other hand, however, the physical meaning of
haPWV becomes less tangible, representing an average
between a diastolic PWV in the distal aorta and lower limbs’
arteries and a PWV at the dicrotic notch pressure for the
proximal aorta (Fig. 2). Therefore, DBP probably under-
estimates the actual pressure at which haPWV is calculated.
Takahashi et al. [44] used similar methodological argu-
ments to support the use of Pm over DBP, and stated that as
the dicrotic notch is close to SBP, the PWV calculated over
tb is approximately the PWV at SBP. Conversely, the PWV
calculated over tba is determined at DBP. Therefore, Pm, the
arithmetic mean between SBP and DBP, would represent
the optimal choice for haPWV. However, typical brachial
BP waveforms show that the pressure at the dicrotic notch
in the brachial artery is approximately 0.55
DBPþ
0.45
 SBP, hence, much closer to MBP or Pm than to
SBP [45]. Following the assumption of constant b0 in the
arterial tree at the basis of CAVI and CAVI0 and knowing the
heart-to-brachial and heart-to-ankle arterial path lengths
[46], the haPWV-relevant pressure can be estimated to be
approximately equal to 0.91
DBPþ 0.09
 SBP (see
Appendix 3, http://links.lww.com/HJH/B719 for full calcu-
lations), that is, much closer to DBP than to Pm or to MBP
(Fig. 5).
In addition to the previous argument, Shirai et al. [30]
suggested that CAVI0 is largely dependent on DBP, which
may vary along long arterial pathways. However, several
studies reported that DBP and MBP are relatively constant
along most parts of the arterial tree, whereas SBP signifi-
cantly increases while moving downstream in the circula-
tion because of pressure amplification [48,49]. It is worth
noting that Pm is not equal to MBP and that Pm is strongly
dependent on SBP. Therefore, the inaccuracy introduced
by regional changes in DBP is deemed to be considerably
smaller than that caused by regional differences in SBP,
reflecting on Pm. In conclusion, although DBP might not be
the exact pressure at which haPWV is determined, it likely
represents a more accurate approximation of the haPWV-
relevant pressure than Pm and has the advantage of being
location-independent.
Notably, haPWV (and hence CAVI/CAVI0) is less influ-
enced by brachial artery stiffness than baPWV. Whereas
baPWV directly and negatively depends on brachial artery
stiffness, haPWV is only influenced by the brachial artery’s
stiffness difference between diastolic and dicrotic notch
pressures. This subject is further detailed in Appendix 4,
http://links.lww.com/HJH/B719.
Finally, Ato [50] raised concerns pertaining to the three-
piecewise linear conversion of b into CAVI [21]. As con-
ceded by the authors, b is an index of arterial stiffness per
se, although still pressure-dependent. Although the three-
piecewise linear conversion was originally introduced to
transform the dimensionless b into a PWV-like index that
would match the Hasegawa PWV [23], this conversion
unnecessarily complicates the relationship between differ-
ences in b and differences in CAVI. As, nowadays, CAVI is
likely more widely used than the Hasegawa PWV, this
conversion is no longer necessary and should ideally
be avoided.
In conclusion, the introduction of CAVI – based on
measurement of heart-ankle PWV – represented a signifi-
cant step forward by correcting for the pressure-depen-
dency of inter-individual differences in PWV. However, two
methodological aspects of CAVI rendered this metric less
pressure-independent than initially thought and CAVI0 was
then introduced to correct for them by substituting the
pressure-dependent b with b0 and by substituting the
approximated derivative in the Bramwell–Hill equation
with an exact derivative at the DBP. The advantage of
the first correction is clear: the corrective effect of the
logarithmic term in CAVI0 is substantial, when the study
groups show a large difference in DBP. The second correc-
tion is less clear, while it raises the more fundamental
question of which ‘pressure’ governs the pressure-depen-
dency exhibited by the haPWV (Fig. 2). At present, most
studies comparing CAVI and CAVI0 have a cross-sectional
design (Table 1) and, hence, are not well suited to address
this question. The few preliminary longitudinal studies we
reviewed have limitations pertaining to parallel effects on
pressure as well as arterial tone, with the latter influencing
intrinsic arterial stiffness. In the present analysis, we
showed that the haPWV-relevant pressure is much more
closely approximated by DBP than by Pm. Hence, our
review supports the utility of CAVI0 as an enhancement
of CAVI to improve the pressure-independent assessment
of arterial stiffness.
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FIGURE 5 DBP offers a close approximation of PhaPWV. Numbers presented for a
normotensive person with SBP/DBP¼120/80 mmHg. Note that in this example,
the difference between Pm and PhaPWV is three times the difference between
PhaPWV and DBP. PhaPWV, relevant pressure for haPWV (calculation details in
Appendix 2, http://links.lww.com/HJH/B719); MBP, mean blood pressure (calcu-
lated as 0.4
 SBPþ0.6
DBP [47]); Pm, mid-blood pressure (arithmetic mean of
SBP and MBP).
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